Results 1 to 10 of about 30,843 (290)
Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine [PDF]
Substance P binds to the Neurokinin-1 (NK-1) receptors found in the emetic center of the central nervous system (CNS) to induce emesis. Maropitant is a selective NK-1 receptor antagonist that inhibits the binding of substance P to NK-1 receptors and is ...
K Sharun+7 more
doaj +1 more source
Tratamiento de la emesis inducida por citotóxicos [PDF]
Nausea and vomiting are important side effects of most chemotherapy anticancer drugs, since nearly two thirds of the patients under chemotherapy have this toxicity in absence of antiemetic treatment.
Miguel Martín, Sara López
doaj +2 more sources
Utilizarea băuturilor de tip Coca-Cola în patologia gastrică la pacienţii pediatrici [PDF]
În faţa tendinţei relativ frecvente a multor persoane – cadre medicale sau nu – de a administra băuturi carbogazoase de tipul Coca-Cola în cazul unor simptome gastrice de tip greaţă sau vărsături la pacienţii pediatrici sau adulţi, am încercat să ...
Cristina Munteanu
doaj +1 more source
Use of Coca-Cola drinks in gastric pathology in pediatric patients [PDF]
Facing us the relatively frequent tendency of many people – medical professionals or not – to administer Coca-Colatype carbonated beverages in the case of nausea-type gastric symptoms or vomiting in pediatric or adult patients, we have tried to ...
Cristina Munteanu
doaj +1 more source
ObjectiveThe purpose of this study was to evaluate the cost-effectiveness and budget impact of fosaprepitant (FosAPR)-containing regimen for the prevention of chemotherapy-induced nausea and vomiting (CINV) among patients receiving high emetogenic ...
Xinglu Xu+7 more
doaj +1 more source
Background Various predictive models have been developed which incorporates patient risk factors into the selection of optimal antiemetic therapy, one of which is chemotherapy-induced nausea and vomiting (CINV) risk scoring system developed by ...
Anita D’Souza+8 more
doaj +1 more source
Temsirolimus is a prodrug form of sirolimus (rapamycin). With its analogs (everolimus, ridaforolimus, and rapamycin), it forms a group of anticancer agents that block the activity of one of the two mammalian targets of rapamycin (mTOR) complexes, mTORC1.
Louiza Belkacemi+2 more
doaj +1 more source
Comparative Study of Ondansetron and Palonosetron for Prevention of Nausea and Vomiting Following Upper Abdominal Surgeries under General Anaesthesia: A Randomised Control Trial [PDF]
Introduction: Postoperative Nausea and Vomiting (PONV) is a common entity following surgical procedure. It may result into serious complication like aspiration of gastric contents, prolonged recovery period.
Deepak Premnarayan Gupta, Vijay Chandak
doaj +1 more source
Comparative Study of Lidocaine and Palonosetron Pretreatment in Reduction of Propofol Induced Injection Pain [PDF]
Introduction: Propofol is very popular as an induction agent in modern day anaesthesia because of its favourable pharmacodynamics and fewer side effects. Any pain pre or post-anaesthesia leads to patient dissatisfaction.
Suruchi Ambasta, Swagat Mahapatra
doaj +1 more source